Other OTC Pharmaceuticals - Southern Africa

  • Southern Africa
  • The revenue generated in the Other OTC Pharmaceuticals market in Southern Africa amounts to US$168.50m in 2024.
  • It is projected to experience an annual growth rate of 1.05% (CAGR 2024-2029).
  • When compared to global figures, the majority of revenue, which is US$7,171.00m in 2024, is generated the in the United States.
  • In terms of per person revenues, US$2.41 is generated in 2024.
  • In Southern Africa, there is a growing demand for herbal and traditional OTC pharmaceutical products.

Key regions: United States, Brazil, Europe, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Southern Africa has been experiencing steady growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development.Customer preferences in Southern Africa have played a significant role in the growth of the Other OTC Pharmaceuticals market. Consumers in the region have shown a preference for self-medication and over-the-counter remedies for common ailments. This is driven by factors such as convenience, cost-effectiveness, and a desire for quick relief. The availability of a wide range of OTC products in pharmacies and retail outlets has catered to these preferences, further fueling the market growth.Trends in the market have also contributed to the development of the Other OTC Pharmaceuticals market in Southern Africa. One notable trend is the increasing adoption of traditional medicine and natural remedies. Many consumers in the region have a cultural affinity for traditional healing practices, and this has led to a growing demand for herbal and natural OTC products. Manufacturers have responded to this trend by introducing a variety of herbal remedies and traditional medicines, which have gained popularity among consumers.Local special circumstances in Southern Africa have also influenced the growth of the Other OTC Pharmaceuticals market. The region has a high burden of infectious diseases, such as malaria and HIV/AIDS, which has led to a significant demand for OTC treatments for these conditions. Additionally, the lack of access to healthcare facilities in some areas has driven consumers to rely on OTC medications for self-care. The affordability and availability of OTC products make them a viable option for many individuals who may not have access to prescription medications or healthcare services.Underlying macroeconomic factors have also contributed to the development of the Other OTC Pharmaceuticals market in Southern Africa. The region has experienced economic growth in recent years, leading to an increase in disposable income and a growing middle class. This has resulted in higher healthcare expenditure and an increased willingness to spend on OTC medications. Additionally, improvements in healthcare infrastructure and the expansion of retail networks have made OTC products more accessible to consumers in remote areas.In conclusion, the Other OTC Pharmaceuticals market in Southern Africa is developing due to customer preferences for self-medication, the adoption of traditional medicine and natural remedies, local special circumstances such as the burden of infectious diseases and lack of access to healthcare, and underlying macroeconomic factors such as economic growth and improved healthcare infrastructure. These factors have created a conducive environment for the growth of the market in the region.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)